Cadens Medical Imaging partners with Hisense Medical to launch 2D/3D Univiewer in China

NewsGuard 100/100 Score

Cadens Medical Imaging Inc. a Montreal-based startup company, announced today the conclusion of a multimillion dollar licensing and technological collaboration with Chinese multinational Hisense Medical Co. The announcement was made today in Shanghai during a ceremony presided over by Quebec's Prime Minister, Philippe Couillard, who is conducting an Economic Mission in China on behalf of the Province of Quebec.

Under provisions of the agreement, Cadens Medical Imaging will be partnering with Hisense Medical Co. to introduce a unique 2D/3D Univiewer software platform to the Chinese market. This innovative technology is designed to provide universal image viewing across a hospital setting, delivering simplicity and productivity to medical experts during cancer-screening procedures. This platform is designed to enhance current picture archiving and communication systems (PACS) and health information technology infrastructures (Vendor Neutral Archives - VNA).

«Our software technology has proven to be an innovative tool that facilitates the work of radiologists by providing them with a rapid analysis of lesions following a cancer-screening procedure, while enhancing the degree of diagnostic confidence in its results,» said Mr. Jean-Pierre Robert, President and CEO of Cadens Medical Imaging. «We are excited with this first commercial agreement and the perspective of future cooperation with Hisense Medical Co., which will prove to be an excellent showcase for a medical technology that has been developed exclusively in Quebec,» he added.

«We are very proud to have the opportunity to introduce this new technological platform to China's medical community and cancer patients,» said Mr.Chuan Gao, CEO of Hisense's Medical Co. «The UniViewer 2D/3D will consolidate our leadership position in the fast-developing field of healthcare provisioning in our country,» he added.

Source:

Cadens Medical Imaging

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Deep learning shines a new light on Parkinson's detection through the eye